MarketLens
Sign Up

What Does Tango Therapeutics' $600 Million Offering Mean for Its Financial Runway

5 months ago
SHARE THIS ON:

What Does Tango Therapeutics' $600 Million Offering Mean for Its Financial Runway

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•2 months ago

Kardigan: Funded Precision Cardiology Offers More Than Pipeline Diversification

Kardigan holds $660.7M in liquid assets, funding 2–3 years of runway for three precision cardiology programs targeting genetic DCM, moderate CAVS, and post-hospitalization ASH. Pivotal 2027 readouts w...
Stock News•3 months ago

Tango Therapeutics: Promising Early Data, But A Long Road Ahead

Tango Therapeutics' vopimetostat plus daraxonrasib showed an unusually strong early pancreatic-cancer signal in a small, previously treated cohort. A planned front-line Phase 3 trial could expand the ...
Stock News•4 months ago

Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants

Q32 Bio priced a $200M public offering of ~11M shares and pre-funded warrants at $18.25/share, diluting existing holders to fund clinical development.

Breaking News

View All →

Top Headlines

View More →
Stock News•19 minutes ago

Nvidia (NVDA) Q3 Earnings and Revenues Beat Estimates

Stock News•22 minutes ago

Nvidia is abandoning China after Jensen Huang's ouster

Stock News•29 minutes ago

Nvidia: Blowout Earnings, Huge Guidance, Insane 0.2x PEG

Stock News•36 minutes ago

Nvidia Results Show Resilience, New Street's Chkaiban Says

Stock News•37 minutes ago

Nvidia Delivers Solid Outlook in First Post-Huang Earnings